Healthcare marketing communication specialists Onyx Health has marked a year of continued growth and expansion with Trevor Pill's appointment as executive director.
Novartis exited novel antibiotics R&D three years ago, but is clearly still interested in the category – its Sandoz unit has just spent $350 million buying GlaxoSmithKline’s cephalospor
Rob Wood has acquired a large minority stake in performance-io through a multimillion-pound deal that will see him join the specialist online performance marketing agency’s executive board.